TY - JOUR
T1 - Vascular Parkinsonism
T2 - Deconstructing a Syndrome
AU - Vizcarra, Joaquin A.
AU - Lang, Anthony E.
AU - Sethi, Kapil D.
AU - Espay, Alberto J.
N1 - Publisher Copyright:
© 2015 International Parkinson and Movement Disorder Society.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Progressive ambulatory impairment and abnormal white matter (WM) signal on neuroimaging come together under the diagnostic umbrella of vascular parkinsonism (VaP). A critical appraisal of the literature, however, suggests that (1) no abnormal structural imaging pattern is specific to VaP; (2) there is poor correlation between brain MRI hyperintensities and microangiopathic brain disease and parkinsonism from available clinicopathologic data; (3) pure parkinsonism from vascular injury ("definite" vascular parkinsonism) consistently results from ischemic or hemorrhagic strokes involving the SN and/or nigrostriatal pathway, but sparing the striatum itself, the cortex, and the intervening WM; and (4) many cases reported as VaP may represent pseudovascular parkinsonism (e.g., Parkinson's disease or another neurodegenerative parkinsonism, such as PSP with nonspecific neuroimaging signal abnormalities), vascular pseudoparkinsonism (e.g., akinetic mutism resulting from bilateral mesial frontal strokes or apathetic depression from bilateral striatal lacunar strokes), or pseudovascular pseudoparkinsonism (e.g., higher-level gait disorders, including normal-pressure hydrocephalus with transependimal exudate). These syndromic designations are preferable over VaP until pathology or validated biomarkers confirm the underlying nature and relevance of the leukoaraiosis.
AB - Progressive ambulatory impairment and abnormal white matter (WM) signal on neuroimaging come together under the diagnostic umbrella of vascular parkinsonism (VaP). A critical appraisal of the literature, however, suggests that (1) no abnormal structural imaging pattern is specific to VaP; (2) there is poor correlation between brain MRI hyperintensities and microangiopathic brain disease and parkinsonism from available clinicopathologic data; (3) pure parkinsonism from vascular injury ("definite" vascular parkinsonism) consistently results from ischemic or hemorrhagic strokes involving the SN and/or nigrostriatal pathway, but sparing the striatum itself, the cortex, and the intervening WM; and (4) many cases reported as VaP may represent pseudovascular parkinsonism (e.g., Parkinson's disease or another neurodegenerative parkinsonism, such as PSP with nonspecific neuroimaging signal abnormalities), vascular pseudoparkinsonism (e.g., akinetic mutism resulting from bilateral mesial frontal strokes or apathetic depression from bilateral striatal lacunar strokes), or pseudovascular pseudoparkinsonism (e.g., higher-level gait disorders, including normal-pressure hydrocephalus with transependimal exudate). These syndromic designations are preferable over VaP until pathology or validated biomarkers confirm the underlying nature and relevance of the leukoaraiosis.
KW - Higher-level gait disorder
KW - Normal-pressure hydrocephalus
KW - Vascular parkinsonism
KW - White matter ischemic disease
UR - http://www.scopus.com/inward/record.url?scp=84931957542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84931957542&partnerID=8YFLogxK
U2 - 10.1002/mds.26263
DO - 10.1002/mds.26263
M3 - Review article
C2 - 25997420
AN - SCOPUS:84931957542
SN - 0885-3185
VL - 30
SP - 886
EP - 894
JO - Movement Disorders
JF - Movement Disorders
IS - 7
ER -